Anatumomab mafenatox - HY-P99436
Nur noch %1 verfügbar
Catalog #
HY-P99436
Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99436/Anatumomab-mafenatox-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room temperature |
| Application | COVID-19-immunoregulation |
| Alternative Names | ABR-214936 |
| CAS | 1370261-50-9 |
| MWT | N/A |
| Solubility | 10 mM in DMSO |
| Clinical Information | No Development Reported |
| Target | Others |
| Application: | COVID-19-immunoregulation |
|---|